Mucoadhesive pharmaceutical compositions of corticosteroids

Patent metadata

Field	Value
Publication number	US-12539306-B2
Application number	US-201917288385-A
Country	US
Kind code	B2
Filing date	Oct 23, 2019
Priority date	Oct 24, 2018
Publication date	Feb 3, 2026
Grant date	Feb 3, 2026

Abstract

Described herein are mucoadhesive pharmaceutical compositions of corticosteroids, as well as methods of making such pharmaceutical compositions, and therapeutic methods using them. The compositions typically comprise a corticosteroid in a mucoadhesive system, wherein the mucoadhesive system comprises a rheology-modifying agent and a vehicle for the corticosteroid. The compositions are particularly useful for treating inflammatory conditions of the esophagus, such as eosinophilic esophagitis, or inflammatory bowel disease.

First claim

What is claimed is:

1 . A mucoadhesive pharmaceutical corticosteroid composition comprising:
(a) budesonide in an amount from 0.02 to 0.06% w/w of the composition, (b) glycerin in an amount from 40 to 70% w/w of the composition, (c) xanthan gum in an amount from 0.25 to 1.5% w/w of the composition, and (d) water, optionally comprising an aqueous acidic buffer, wherein the composition has a pH of from about 4.5 to about 7, is flowable at room temperature, and has a viscosity at room temperature of about 3000-9000 cps.

2 . The composition of claim 1 , further comprising propylene glycol in an amount up to 20% w/w of the composition.

3 . The composition of claim 1 , wherein:
(a) the budesonide is present in an amount of about 0.05% w/w of the composition, (b) the glycerin is present in an amount of about 50% w/w of the composition, (c) the xanthan gum is present in an amount of about 1% w/w of the composition, and the composition optionally further comprises sucralose in an amount of about 0.05% w/w of the composition.

4 . The composition of claim 1 , further comprising one or more of:
a flavoring agent, a preservative, and an antioxidant.

5 . The composition of claim 1 , wherein the composition is a suspension.

6 . The composition of claim 1 , wherein the composition is a solution.

7 . The composition of claim 1 , wherein the composition is substantially free of preservatives.

8 . The composition of claim 1 , wherein the composition exhibits a work of adhesion of 150 to 350 g/s, when assessed at room temperature using a texture analyzer and applying 1 mL of the composition to a hydrophilic polysulfone test membrane having a pore size of 0.45 pm and a diameter of 22 mm and recording the force needed to detach the composition as a function of elongation.

9 . The composition of claim 1 , formulated for oral administration.

10 . The composition of claim 9 , provided in a unit dose package containing from 1 to 10 mL of the composition.

11 . The composition of claim 1 , formulated for rectal administration.

12 . A method of preparing a mucoadhesive pharmaceutical corticosteroid composition of claim 1 , comprising preparing a solution or suspension comprising budesonide, glycerin, xanthan gum, and, optionally, aqueous acidic buffer.

13 . The composition of claim 1 , wherein the aqueous acidic buffer is selected from a citric acid buffer and an acetate buffer.

14 . The composition of claim 1 , wherein the composition has a pH of from 4.8 to about 5.8.

Assignees

• Ferring Bv

Inventors

• Grenier Arnaud
• Carrara Dario

Classifications

• A61K47/36

  Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin · CPC title

• A61K47/26

  Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin · CPC title

• A61K47/12

  Carboxylic acids; Salts or anhydrides thereof · CPC title

• A61K47/10

  Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers · CPC title

• A61K31/58

  containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin (digitoxin {A61K31/7048}) · CPC title